1. I. Böttcher, A. Schweizer, M. Glatt and H. Werner,CGP 28237 (ZK 34228), a novel nonsteroidal anti-inflammatory agent without gastro-intestinal ulcerogenicity in rats. Abstract A 220, 2nd World Conference on Inflammation, Bioscience Ediprint, Monte Carlo (1987) in press.
2. M. E. J. Billingham and M. J. Tucker,Correlation between the rise in acute phase proteins and histological evidence of ulceration in the rat following indomethacin treatment. Proceedings of the British Pharmacological Society, 17–20th July 1979, pp. 450–451.
3. B. S. Andrews, R. A. Eisenberg, A. N. Theofilopoulos, S. Izui, C. B. Wilson, P. J. McConahey, E. D. Murphy, J. B. Roths and F. J. Dixon,Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains. J. Exp. Med.148, 1198–1215 (1978).
4. Ch. Rordorf-Adam, D. Serban, A. Pataki and M. Grüninger,Serum amyloid P-component and autoimmune parameters in the assessment of arthritis activity in MRL/1pr/1pr mice. Clin. exp. Immunol.61 509–516 (1985).
5. D. Serban and Ch. Rordorf-Adam,Quantification of serum amyloid P component by an enzyme-linked immunoassay. J. Immunol. Methods90, 159–164 (1986).